Cover Image

Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia

Diana Sánchez-Calderón,1 Adriana Pedraza,2 Catalina Mancera Urrego,2 Aurelio Mejía-Mejía,2 Ana Lorena Montealegre-Páez,3 Sandra Perdomo3 1Faculty of Medicine, Universidad El Bosque, Bogotá, Colombia; 2Universidad del Rosario, Bogotá, Colombia; 3Institute of Nutrition, Genetics, and Metabolism Resear...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sánchez-Calderón D (Author), Pedraza A (Author), Mancera Urrego C (Author), Mejía-Mejía A (Author), Montealegre-Páez AL (Author), Perdomo S (Author)
Format:	Book
Published:	Dove Medical Press, 2020-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer
by: Sina Halvaei, et al.
Published: (2018)

Liquid Biopsy
Published: (2019)

Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges
by: Mariana Chantre-Justino, et al.
Published: (2022)

Cost of illness of HER2-positive and metastatic and recurrent HER2-positive breast cancer - a Danish register-based study from 2005 to 2016
by: M. Spanggaard, et al.
Published: (2022)

Liquid biopsy and glioblastoma
by: Robert H. Eibl, et al.
Published: (2023)

Liquid Biopsy in Advanced Colorectal Cancer: Clinical Applications of Different Analytes
by: Marco Donatello Delcuratolo, et al.
Published: (2023)

Liquid Biopsy Profiling with Multiple Tests in Patients with Metastatic Breast Cancer
by: Nikki Higa, et al.
Published: (2024)

PHARMACOECONOMIC EVALUATION OF RIBOCICLIB FOR THE FIRST-LINE TREATMENT OF HR-POSITIVE HER2-NEGATIVE ADVANCED BREAST CANCER
by: N. A. Avksentyev, et al.
Published: (2018)

POSSIBILITIES OF THERAPY OF HER-2-POSITIVE REGIONAL BREAST CANCER
by: A. S. Belokhvostova, et al.
Published: (2015)

Cost-effectiveness analysis of trastuzumab deruxtecan versus trastuzumab emtansine for HER2-positive breast cancer
by: Jiangping Yang, et al.
Published: (2022)

Educational Case: HER-2 Positive Breast Cancer
by: Julia Jennings MD, et al.
Published: (2021)

Non-invasive Technology Advances in Cancer-A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
by: Mark R. Openshaw, et al.
Published: (2020)

Cost-effectiveness analysis of trastuzumab deruxtecan in patients with HER2-low advanced breast cancer based on DESTINY-Breast04
by: Mei Zhan, et al.
Published: (2023)

Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
by: Anne Julienne Genuino, et al.
Published: (2019)

Recent advances in liquid biopsy in cancers: Diagnosis, disease state and treatment response monitoring
by: Zhixian Chen, et al.
Published: (2022)

Case report: Successful treatment of a rare HER2-positive advanced breast squamous cell carcinoma
by: Gui Wang, et al.
Published: (2024)

Neratinib for HER2-positive breast cancer with an overlooked option
by: Liting Guo, et al.
Published: (2023)

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
by: Luying Xu, et al.
Published: (2024)

Editorial: Liquid-biopsy-guided biomarker and drug discovery
by: Olesya A. Kharenko, et al.
Published: (2024)

Factors related to healthcare costs of road traffic accidents in Bucaramanga, Colombia
by: Raquel Rivera Carvajal, et al.
Published: (2022)

The prognosis of patients treated with everolimus for advanced ER‐positive, HER2‐negative breast cancer is driven by molecular features
by: Hélène Salaün, et al.
Published: (2024)

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer
by: Chen Xu, et al.
Published: (2017)

Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2– advanced or metastatic breast cancer in Spain
by: Galve-Calvo E, et al.
Published: (2018)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021)

Multilineal treatment strategy of HER2-positive metastatic breast cancer (clinical case)
by: A. F. Nasretdinov, et al.
Published: (2021)

Evaluación nutricional en un grupo de adolescentes embarazadas en Cartagena, Colombia: Estudio de corte transversal A cross sectional study of nutrition in a group of pregnant adolescents from Cartagena, Colombia
by: Edgar Rivas-Perdomo, et al.
Published: (2005)

Liquid Biopsy perspectives theranostics and personalized oncology
by: C Daniel Ascencio González
Published: (2020)

Role of liquid biopsy for thoracic cancers immunotherapy
by: Raimondo Di Liello, et al.
Published: (2020)

Application of liquid biopsy in lung cancer management
by: Shraddhanjali Satapathy, et al.
Published: (2024)

Extracellular Vesicles and the Promise of Continuous Liquid Biopsies
by: Don Armstrong, et al.
Published: (2018)

The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer
by: Zihong Wu, et al.
Published: (2023)

HER-2-positive metastatic breast cancer: new possibilities for therapy
by: E. V. Artamonova, et al.
Published: (2014)

Clinicopathologic characteristics of HER2-positive pure mucinous carcinoma of the breast
by: Yunjeong Jang, et al.
Published: (2020)

Circulating tumor cells as a "real-time liquid biopsy": Recent advances and the application in ovarian cancer
by: Hei-Jen Jou, et al.
Published: (2022)

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
by: Paola Ulivi, et al.
Published: (2021)

Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study
by: Hui-Hsia Hsieh, et al.
Published: (2023)

The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer
by: Chilà G, et al.
Published: (2021)

Role of targeted therapy in the treatment of HER-2-positive breast cancer brain metastases
by: G. A. Dashyan, et al.
Published: (2016)

Evaluación nutricional en un grupo de adolescentes embarazadas en Cartagena, Colombia. Estudio de corte transversal
by: Edgar Rivas-Perdomo, et al.
Published: (2005)

Trastuzumab deruxtecan versus chemotherapy for patients with HER2-low advanced breast cancer: A US-based cost-effectiveness analysis
by: Youwen Zhu, et al.
Published: (2022)